Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by westcoast1000on Sep 17, 2020 2:03pm
143 Views
Post# 31577396

RE:PGX (Y-BG) commercial plant in Germany

RE:PGX (Y-BG) commercial plant in GermanyThankas Ciao.

I also wonder whether the Germany site selection has to do with European partner possibilities. Symrise has loaned us capital in the past for completion of the new facility, IIRC. 

But there is no particular reason Symrise would be involved in anything like the PGX-YBC trial.

Is this going to be a Canadian trial? I personally hope so. One would also hope they have investigators and a research team lined up. The Montreal heart group does not do work on inhalable lung treatments, but they may have colleagues who do.

Regardless we should be hearing a lot more about this trial, in order to demonstrate it will proceed with competent clinically experienced investigators and some pharma company that has experience in completing clinical trials and getting drugs approved.
<< Previous
Bullboard Posts
Next >>